Randomised controlled trialindependent cross-checkabstract checked★ key study I-FAT-102 in-depth review

Swapping ghee for rapeseed oil improved fatty liver and cholesterol

The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance and anthropometric measurements in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial.

Overview

Maleki Sedgi F et al.. Br J Nutr 2024 · PMID 38501177 · DOI 10.1017/S0007114524000564

Less liver fat, LDL -7.5 mg/dL, triglycerides -40 mg/dL over 12 weeks.

Does the study support the specific claim? No · Methodological quality: low

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test replacing ghee with rapeseed oil.

How was the study done?

Randomised trial, 12 weeks.

How many people, animals or samples were studied?

110 Iranian adults with fatty liver.

What was actually found?

Better liver fat, lipids, sugar and weight.

How large was the observed effect?

LDL -7.5 mg/dL.

What do the results mean in everyday life?

Plant oil is a better daily cooking fat than ghee.

What are the study's limitations?

Open label; weight loss.

What does it say about Elawady's specific claim?

Contradicts 'ghee does not affect arteries' indirectly.

Do the results apply to Germany and Europe?

Middle East; relevant to Egypt.

What can explicitly not be concluded from this study?

Cannot show fewer heart attacks.

Scientific in-depth review

1. Full reference

Authors
Maleki Sedgi F et al.
Journal
Br J Nutr
Year
2024
Identifier
PMID 38501177 DOI 10.1017/S0007114524000564
Verification
verified – PubMed efetch 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Does replacing ghee with rapeseed oil improve NAFLD and metabolic markers?

3. Study design and population

Study design
Randomised controlled trial – 12-week randomised controlled trial (advice-based substitution)
Population

Adults with NAFLD who consumed ghee daily (Iran)

Country

Iran

Period

12 weeks

Sample size

110 (70 men, 40 women)

Inclusion and exclusion criteria

NAFLD; daily ghee users

4. Methods and endpoints

Exposure / intervention

Replace ghee with same amount of rapeseed oil

Comparator

Continue ghee; healthy-diet advice

Endpoints

Steatosis, liver enzymes, lipids, glycaemia, anthropometry

Statistical methods

Between-group comparisons

5. Actual results

Results

Steatosis reduced more with rapeseed oil (P<0.001); changes in intervention group: ALT -14.4, GGT -1.8, TAG -39.7 mg/dL, total cholesterol -17.2 mg/dL, LDL -7.5 mg/dL, fasting glucose -7.5 mg/dL, insulin -3.05 mU/L, HOMA-IR -0.9, weight -4.3 kg, waist -5.6 cm.

Absolute risks

not applicable (surrogate outcomes)

Authors' conclusion

Consumption of rapeseed oil instead of ghee caused improvements in liver steatosis and enzymes, glycaemic variables and anthropometric measurements.

6. Strengths

  • Randomised
  • Ghee-specific
  • Middle Eastern population

7. Weaknesses

  • Unblinded advice trial
  • Weight loss in intervention arm confounds lipid changes
  • Abstract reports within-group changes; some figures (BMI -0.04) look inconsistent
  • Short

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Open label; co-interventions.

9. Assessment of the statistical interpretation

LDL -7.5 mg/dL = about 0.19 mmol/L; by CTT scaling about 5% fewer vascular events if sustained (assumption; stats/C-FAT-01_butter_ghee.py).

10. Relevance to the specific claim

Direct randomised evidence that replacing ghee by a plant oil lowers LDL cholesterol and improves metabolic markers in regional ghee users.

11. Independent contrary findings

Uncontrolled ghee-feeding studies report no LDL rise (not added; very low quality).

12. Transferability to Germany and Europe

Highly relevant to Egyptian ghee use.

13. Overall methodological judgement

Low-to-moderate quality; consistent with the saturated-fat/LDL evidence.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitylow
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Hard outcomes.

15. Linked fact checks